Switching to retatrutide Moving from a dual agonist (tirzepatide) to a triple agonist (retatrutide) is generally smoother because retatrutide maintains GLP-1 and GIP activation while adding glucagon receptor stimulation
The main issues people see are: Flushing Itching Elevated liver enzymes Although there arent many reported risks, there is a lack of research on humans, which limits the availability of definitive safety information
Hypoglycemic episodes, defined according to the ADA criteria ( Statistical methods For analysis purposes, groups were formed according to KDIGO CKD risk criteria (see above) in order to perform comparisons and were as follows: no/low CKD risk group
Blood Sugar Imbalance Consumption of sugar-rich foods by our ancestors was much different from the present
In pulmonary vein cardiomyocytes (Chan et al., 2023), GLP-1 amide modulates ionic currents by decreasing L-VGCC and Na + /Ca 2+ exchanger current while increasing sarcoplasmic reticulum Ca 2+ content
Building a Sustainable Long-Term Retatrutide Protocol If you are planning to use Retatrutide for six months or longer, a few practices can help maximize safety and results while reducing the likelihood of problems that force you to stop earlier than planned